Pricing Log in Create free account
Friday 6 November 2026 Export MDGL’s income statement to Excel — free account

Madrigal Pharmaceuticals, Inc.

MDGL Healthcare Biotechnology

Madrigal Pharmaceuticals, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $958.4 million, up 432.1% from fiscal 2024.

Revenue
+50.1%
EPS
+147.3%
Free cash flow
+53.5%
Total debt
+0.45%

Quarter to September 2026, against a year earlier

390.52 9.58 −2.39%
Market cap
$9.3B
P/E
0.0×
Fwd P/E
−68.8×
Dividend yield
—
F-score
n/a
Altman Z
10.48
Beneish M
0.50
Dividend safety
n/a
Overview Business Profile Earnings & Analysis
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Segments Valuation Filings

Madrigal Pharmaceuticals, Inc. (MDGL) Current ratio

Alert me on Current ratio

Madrigal Pharmaceuticals, Inc.'s current ratio at the end of the quarter to 30 September 2026 was 3.1×, down 1.0× from fiscal 2025 (4.0×). Over the past ten years it has ranged from 0.0× (fiscal 2015) to 57.5× (fiscal 2018); the current reading is higher than 36% of that period. That is below the Biotechnology industry median of 4.9× and in line with the Healthcare sector median of 3.1×.

Current ratio, annual

Embed this chart

Annual newest first

Period Current ratio Change
FY2025 4.0× (34.20%)
FY2024 6.1× 13.51%
FY2023 5.4× 72.40%
FY2022 3.1× (11.81%)
FY2021 3.5× (42.27%)
FY2020 6.1× (65.03%)
FY2019 17.5× (69.52%)
FY2018 57.5× 200.87%
FY2017 19.1× 122.46%
FY2016 8.6× 115,910.81%

Quarterly newest first

Period Current ratio Change
Sep 2026 3.1× (4.71%)
Jun 2026 3.2× (8.32%)
Mar 2026 3.5× (12.94%)
Dec 2025 4.0× 16.69%
43 more quarters

Against its own ten years

Low 0.0× High 57.5×
Ten-year median 6.1×
Current reading's percentile 36

Current ratio against peers

Company Current ratio
SYRE Spyre Therapeutics, Inc. compare 27.4×
PTGX Protagonist Therapeutics, Inc. compare 21.7×
KRYS Krystal Biotech, Inc. compare 7.9×
CAI Caris Life Sciences,�Inc. compare 6.7×
IBRX ImmunityBio, Inc. compare 5.7×
TGTX TG Therapeutics, Inc. compare 4.3×
CYTK Cytokinetics, Incorporated compare 3.4×
MDGL Madrigal Pharmaceuticals, Inc. 3.1×
TWST Twist Bioscience Corporation compare 2.7×
Biotechnology industry median 4.9×
Healthcare sector median 3.1×
Market median 1.6×

What Current ratio is

Current Ratio shows whether a company’s short-term assets are enough to cover the bills and debts it must pay within the next year.

Current Assets (Total) ÷ Current Liabilities (Total)

The full definition of Current ratio →

More on MDGL